Drawing for OBLONE

USPTO serial 79187402

OBLONE

Reviewed by CopyMark Law Group

Reg. 5298666Status 404
Filing date
Status date
Registration date
Oct 3, 2017
Examiner
KHAN, AHSEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OBLONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leslie Bertagnolli

Lisa Gates Baker&McKenzie LLP300 E. Randolph St. Suite 5000Chicago, IL 60601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of osteoporosis; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; dietary supplements, namely, enzyme food supplements, vitamin and mineral food supplements, herbal food supplements and trace element food supplements and dietetic foods adapted for medical use, namely, pasta and crackers, bars, powdered milk, pollen, amino acids and beverages; medical plasters used as material for dressings for medical purposes; wound dressings; medicated compresses for use in application of implants; teeth filling material; dental impression materials; disinfectants; preparations for destroying noxious animals; fungicides; herbicides; all the aforementioned goods for diabetic, oncological and osteoporotic fields, excluding veterinary productsSECTION 71 - CANCELLED—
010Implantable drug delivery systems for the treatment and prevention of diabetes; implantable drug delivery systems for the treatment and prevention of cancer; implantable drug delivery systems for the treatment and prevention of osteoporosis; medical apparatus and instruments for use in surgery for application of implants; applicators for medications and applicators for pharmaceutical use, namely, droppers for use in application of implants; injection devices for pharmaceuticals; medical implants in the nature of drug delivery systems; pharmaceutical implants in the nature of drug delivery systems; drug delivery systems for medical use in delivering pharmaceuticals from containers; infusion pumps to deliver medication; all the aforementioned goods for diabetic, oncological and osteoporotic fields, excluding veterinary productsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 5, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 21, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 18, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 18, 2025INPCINVALIDATION PROCESSED—
Dec 20, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 19, 2024C71TCANCELLED SECTION 71—
Oct 3, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 5, 2019CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 25, 2019CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 16, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 18, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 18, 2018FIMPFINAL DISPOSITION PROCESSED—
Jan 3, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 3, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 15, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 7, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 7, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 10, 2017LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Mar 30, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 30, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 30, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 10, 2017ALIEASSIGNED TO LIE—
Feb 23, 2017NREVNOTICE OF REVIVAL - MAILED—
Feb 23, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2017PETGPETITION TO REVIVE-GRANTED—
Feb 23, 2017PROATEAS PETITION TO REVIVE RECEIVED—
Jan 25, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 25, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 20, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 15, 2016RFNTREFUSAL PROCESSED BY IB—
Jun 29, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 29, 2016RFRRREFUSAL PROCESSED BY MPU—
Jun 29, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016DOCKASSIGNED TO EXAMINER—
Jun 14, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 2, 2016SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance